Literature DB >> 29762090

Alzheimer Disease and Mild Cognitive Impairment: Integrated Pulsed Arterial Spin-Labeling MRI and 18F-FDG PET.

Isabelle Riederer1, Karl Peter Bohn1, Christine Preibisch1, Eva Wiedemann1, Claus Zimmer1, Panagiotis Alexopoulos1, Stefan Förster1.   

Abstract

Purpose To compare PET/MR hypoperfusion and hypometabolism in patients with Alzheimer disease (AD) and mild cognitive impairment (MCI) compared with healthy control (HC) participants. Materials and Methods Maps of cerebral blood flow (CBF; pulsed arterial spin-labeling [ASL] MRI), glucose metabolism (fluorine 18 [18F] fluorodeoxyglucose [FDG] PET), and gray matter (GM) volume (structural T1-weighted MRI) were calculated from integrated PET/MR data in 45 patients with AD (mean age, 69 years ± 9 [standard deviation]; age range, 51-89 years), 20 patients with MCI (mean age, 64 years ± 10; age range, 45-82 years), and 11 HC participants (mean age, 65 years ± 8; age range, 54-80 years) between 2011 and 2014. After preprocessing, voxel-wise analyses of variance, volume of interest, and independent component analyses were performed for comparisons of CBF and glucose metabolism. Results Analyses revealed high overlap between components, regional and quantitative hypoperfusion, and hypometabolism in patients with AD compared with HC participants in precuneus, parietal, temporal, and occipital cortex. In patients with MCI compared with HC participants, FDG PET exclusively demonstrated quantitative hypometabolism and a component in the precuneus. Volume-of-interest analysis in global GM in patients with AD compared with HC participants showed lower CBF (42 mL/100 g per minute ± 8 vs 49 mL/100 g per minute ± 7, respectively; P = .035) and lower FDG uptake (0.8 ± 0.1 vs 1 ± 0.1, respectively; P < .001). Conclusion In patients with AD, pulsed ASL MRI revealed regional and quantitative abnormalities and components similar to 18F-FDG PET with a reduced extent. In patients with MCI, 18F-FDG PET exclusively demonstrated quantitative hypometabolism and a component in the precuneus, indicating higher sensitivity to detect preclinical AD compared with the currently used pulsed ASL MRI sequence. © RSNA, 2018 Online supplemental material is available for this article.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29762090     DOI: 10.1148/radiol.2018170575

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  23 in total

1.  The Relationship Among Glucose Metabolism, Cerebral Blood Flow, and Functional Activity: a Hybrid PET/fMRI Study.

Authors:  Jingjuan Wang; Haiyang Sun; Bixiao Cui; Hongwei Yang; Yi Shan; Chengyan Dong; Yufeng Zang; Jie Lu
Journal:  Mol Neurobiol       Date:  2021-02-01       Impact factor: 5.590

2.  Associations between cerebral blood flow and structural and functional brain imaging measures in individuals with neuropsychologically defined mild cognitive impairment.

Authors:  Chan-Mi Kim; Rachel L Alvarado; Kimberly Stephens; Hsiao-Ying Wey; Dany J J Wang; Elizabeth C Leritz; David H Salat
Journal:  Neurobiol Aging       Date:  2019-11-06       Impact factor: 4.673

3.  Intravoxel incoherent motion diffusion-weighted imaging in the characterization of Alzheimer's disease.

Authors:  Nengzhi Xia; Yanxuan Li; Yingnan Xue; Weikang Li; Zhenhua Zhang; Caiyun Wen; Jiance Li; Qiong Ye
Journal:  Brain Imaging Behav       Date:  2021-09-04       Impact factor: 3.978

4.  Cortical hypoperfusion in patients with idiopathic rapid eye movement sleep behavior disorder detected with arterial spin-labeled perfusion MRI.

Authors:  Yonglu Chen; Changhe Fan; Wanqun Yang; Kun Nie; Xiaoling Wu; Yuelong Yang; Yunjun Yang; Lijuan Wang; Yuhu Zhang; Biao Huang
Journal:  Neurol Sci       Date:  2019-12-02       Impact factor: 3.307

5.  Human Brain Lipidomics: Utilities of Chloride Adducts in Flow Injection Analysis.

Authors:  Paul L Wood; Kathleen A Hauther; Jon H Scarborough; Dustin J Craney; Beatrix Dudzik; John E Cebak; Randall L Woltjer
Journal:  Life (Basel)       Date:  2021-04-28

Review 6.  Multiparametric magnetic resonance imaging and positron emission tomography findings in neurodegenerative diseases: Current status and future directions.

Authors:  Neetu Soni; Manish Ora; Girish Bathla; Chandana Nagaraj; Laura L Boles Ponto; Michael M Graham; Jitender Saini; Yusuf Menda
Journal:  Neuroradiol J       Date:  2021-03-05

7.  Simultaneous PET-MRI imaging of cerebral blood flow and glucose metabolism in the symptomatic unilateral internal carotid artery/middle cerebral artery steno-occlusive disease.

Authors:  Bixiao Cui; Tianhao Zhang; Yan Ma; Zhongwei Chen; Jie Ma; Lei Ma; Liqun Jiao; Yun Zhou; Baoci Shan; Jie Lu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-11-06       Impact factor: 9.236

Review 8.  Dietary Neuroketotherapeutics for Alzheimer's Disease: An Evidence Update and the Potential Role for Diet Quality.

Authors:  Matthew K Taylor; Russell H Swerdlow; Debra K Sullivan
Journal:  Nutrients       Date:  2019-08-15       Impact factor: 5.717

9.  Aberrant cerebral perfusion pattern in amnestic mild cognitive impairment and Parkinson's disease with mild cognitive impairment: a comparative arterial spin labeling study.

Authors:  Song'an Shang; Jingtao Wu; Yu-Chen Chen; Hongri Chen; Hongying Zhang; Weiqiang Dou; Peng Wang; Xin Cao; Xindao Yin
Journal:  Quant Imaging Med Surg       Date:  2021-07

10.  Regional Cerebral Perfusion and Cerebrovascular Reactivity in Elderly Controls With Subtle Cognitive Deficits.

Authors:  Merel van der Thiel; Cristelle Rodriguez; Dimitri Van De Ville; Panteleimon Giannakopoulos; Sven Haller
Journal:  Front Aging Neurosci       Date:  2019-02-19       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.